Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459192) titled 'Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors' on March 4.

Study Type: Observational

Primary Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Condition: Canser

Recruitment Status: Not recruiting

Date of First Enrollment: April 1, 2026

Target Sample Size: 50

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07459192

Disclaimer: Curated by HT Syndication....